- Charles River CEO says it likely won’t be the last manufacturer to break away from cell and gene therapyThree months ago, Charles River Laboratories announced it would shed its manufacturing unit, which has a focus on cell and gene therapies. And, according to its CEO Birgit Girshick, other companies…Endpoints · 1mo ago↗ source
- China gene editing startup YolTech raises $70M to move CRISPR therapies forwardOne of China’s most prolific gene editing companies has raised its biggest round of funding yet, ahead of plans to go public in Hong Kong. While most gene editing companies in the US trimmed their…Endpoints · 1mo ago↗ source
- Oura pushes deeper into healthcare services as part of new ring launchAlongside the debut of Oura's smaller Ring 5, the wearables company on Thursday unveiled its plans to help users integrate health records and translate their ring’s findings into medical care. Ou…